Carbamic Acid

Carbamic Acid

SCHEMBL6411899

C1=Cc2cc3[nH]c(cc4nc(cc5ccc(cc1n2)[nH]5)C=C4)c1ccccc31.NC(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ STAT3 P40763 1/20 0.40
▸ STAT1 P42224 1/20 0.40
▸ HTR7 P34969 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRB1 P18505 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ GABRA4 P48169 1/20 0.39
▸ GABRE P78334 1/20 0.39
▸ GABRA6 Q16445 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27307 0.89 AHR (0.47) KDM4EALDH1A1STAT3STAT1GABRP
SCHEMBL11332400 0.88 STAT3 (0.39) KDM4EALDH1A1STAT3STAT1KMT2A
SCHEMBL11332303 0.88 STAT3 (0.39) KDM4EALDH1A1STAT3STAT1HTR7
SCHEMBL2749736 0.87 AHR (0.45) KDM4EALDH1A1STAT3STAT1GABRP
Carbamic Acid SCHEMBL30568294 0.87 STAT3 (0.38) STAT3STAT1PARP1CHEK2
Carbazole SCHEMBL27824098 0.85 ALDH1A1 (0.50) KDM4EALDH1A1STAT3STAT1KMT2A
Carbazole SCHEMBL27848555 0.84 ALDH1A1 (0.52) KDM4EALDH1A1STAT3STAT1GABRP
Carbazole SCHEMBL28879059 0.82 ALDH1A1 (0.50) KDM4EALDH1A1STAT3STAT1GABRP
Triphenylene SCHEMBL28121394 0.82 STAT3 (0.46) KDM4EALDH1A1STAT3STAT1KMT2A
SCHEMBL11325996 0.81 STAT3 (0.35) KDM4EALDH1A1STAT3STAT1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1450790-A4 PHOTOSENSITIZING CARBAMATE DERIVATIVES MIRAVANT PHARM INC (US) 2005-10-26 — — EP disclosed
US-20040266748-A1 Photosensitizing carbamate derivatives MIRAVANT PHARMACEUTICALS, INC. 2004-12-30 — — US disclosed
EP-1450790-A2 PHOTOSENSITIZING CARBAMATE DERIVATIVES Miravant Pharmaceuticals, Inc. (US) 2004-09-01 — — EP disclosed
WO-2003028628-A2 PHOTOSENSITIZING CARBAMATE DERIVATIVES MIRAVANT PHARMACEUTICALS, INC. (US) 2003-04-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266748-A1 Photosensitizing carbamate derivatives CRY1, CASP3, CRY2 KDM4E 238/4885ALDH1A1 2202/4885STAT3 3053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback